Kev Cai Lij Choj thiab Kev Tswj Hwm
bcbs-gender-affirming-policy-age-language-highlighted.pdf
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1351 - 1360 ntawm 4204
Kev Cai Lij Choj thiab Kev Tswj Hwm
bcbs-gender-affirming-policy-doc-require-highlighted.pdf
Kev Cai Lij Choj thiab Kev Tswj Hwm
bcbs-gender-affirming-policy-hrt-language-highlighted.pdf
Tus kws kho mob
QP88-22 Provider Press: Q2 2022
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022
Tus kws kho mob
QP89-22 Provider Press: Q3 2022
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022
Tus kws kho mob
QP87-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Strensiq® (asfotase alfa)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022
Tus kws kho mob
QP86-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Vtama® (tapinarof)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022
Tus kws kho mob
QP84-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Camzyos™ (mavacamten)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022
Tus kws kho mob
QP85-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Radicava® (edaravone)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022
Tus kws kho mob
QP83-22 MHCP Pharmacy Benefit Exclusion for Somatuline® Depot and Sandostatin® LAR Depot
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2022